The in-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation has not been satisfactorily defined. We addressed this question by studying patients with primary ventricular fibrillation derived from a large study (11,712 patients) of intravenous streptokinase in the treatment of acute myocardial infarction. Ventricular fibrillation was considered to be primary when it complicated a first myocardial infarction not associated with heart failure or shock and occurred within 48 hours of hospital admission. The 332 patients with primary ventricular fibrillation represented an overall incidence of 2.8 percent. A significant excess of in-hospital deaths was found in the patients with primary ventricular fibrillation as compared with those in the reference group (10.8 percent vs. 5.9 percent; relative risk, 1.94; 95 percent confidence interval, 1.35 to 2.78). Thrombolytic treatment with intravenous streptokinase did not afford protection against primary ventricular fibrillation. We observed that being over 65 years old had a protective effect against primary ventricular fibrillation (relative risk, 0.6; 95 percent confidence interval, 0.45 to 0.80). Our data do not indicate whether primary ventricular fibrillation is simply a marker for patients at increased risk of death or a direct cause of the increase in mortality. Our results do show, however, that primary ventricular fibrillation occurring in a coronary care unit is a negative predictor of short-term survival in patients with acute myocardial infarction.
This article has been cited by other articles:
Gheeraert, P. J., De Buyzere, M. L., Taeymans, Y. M., Gillebert, T. C., Henriques, J. P.S., De Backer, G., De Bacquer, D.
(2006). Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J
27: 2499-2510
[Abstract][Full Text]
Kato, M., Dote, K., Sasaki, S., Takemoto, H., Habara, S., Hasegawa, D.
(2004). Intracoronary Verapamil Rapidly Terminates Reperfusion Tachyarrhythmias in Acute Myocardial Infarction. Chest
126: 702-708
[Abstract][Full Text]
Yan, G.-X., Joshi, A., Guo, D., Hlaing, T., Martin, J., Xu, X., Kowey, P. R.
(2004). Phase 2 Reentry as a Trigger to Initiate Ventricular Fibrillation During Early Acute Myocardial Ischemia. Circulation
110: 1036-1041
[Abstract][Full Text]
Mehta, R. H., Harjai, K. J., Grines, L., Stone, G. W., Boura, J., Cox, D., O'Neill, W., Grines, C. L., Primary Angioplasty in Myocardial Infarction (PAMI,
(2004). Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: Incidence, predictors, and outcomes. J Am Coll Cardiol
43: 1765-1772
[Abstract][Full Text]
Wilkinson, J, Foo, K, Sekhri, N, Cooper, J, Suliman, A, Ranjadayalan, K, Timmis, A D
(2002). Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction. Heart
88: 583-586
[Abstract][Full Text]
Tsai, C.-H., Su, S.-F., Chou, T.-F., Lee, T.-M.
(2002). Differential Effects of Sarcolemmal and Mitochondrial KATP Channels Activated by 17beta -Estradiol on Reperfusion Arrhythmias and Infarct Sizes in Canine Hearts. J. Pharmacol. Exp. Ther.
301: 234-240
[Abstract][Full Text]
Tognoni, G.
(2000). The EMIP Project. Eur Heart J
21: 1498-1499
Newby, K. H., Thompson, T., Stebbins, A., Topol, E. J., Califf, R. M., Natale, A.
(1998). Sustained Ventricular Arrhythmias in Patients Receiving Thrombolytic Therapy : Incidence and Outcomes. Circulation
98: 2567-2573
[Abstract][Full Text]
Cheema, A. N., Sheu, K., Parker, M., Kadish, A. H., Goldberger, J. J.
(1998). Nonsustained Ventricular Tachycardia in the Setting of Acute Myocardial Infarction : Tachycardia Characteristics and Their Prognostic Implications. Circulation
98: 2030-2036
[Abstract][Full Text]
Barrabes, J. A., Garcia-Dorado, D., Gonzalez, M. A., Ruiz-Meana, M., Solares, J., Puigfel, Y., Soler-Soler, J.
(1998). Regional expansion during myocardial ischemia predicts ventricular fibrillation and coronary reocclusion. Am. J. Physiol. Heart Circ. Physiol.
274: H1767-H1775
[Abstract][Full Text]
Yusuf, S., Pogue, J.
(1997). Primary Angioplasty Compared With Thrombolytic Therapy for Acute Myocardial Infarction. JAMA
278: 2110-2111
[Abstract]
O'Rourke, M. F., Donaldson, E., Geddes, J. S.
(1997). An Airline Cardiac Arrest Program. Circulation
96: 2849-2853
[Abstract][Full Text]
Eldar, M., Sievner, Z., Goldbourt, U., Reicher-Reiss, H., Kaplinsky, E., Behar, S., SPRINT Study Group,
(1992). Primary Ventricular Tachycardia in Acute Myocardial Infarction: Clinical Characteristics and Mortality. ANN INTERN MED
117: 31-36
[Abstract]
Volpi, A., Cavalli, A., Maggioni, A., Franzosi, M. G., Tognoni, G.
(1989). Prophylactic Lidocaine in Acute MI. JAMA
261: 1278-1279
[Abstract]
MacMahon, S., Collins, R., Peto, R., Koster, R. W., Yusuf, S.
(1988). Effects of Prophylactic Lidocaine in Suspected Acute Myocardial Infarction: An Overview of Results From the Randomized, Controlled Trials. JAMA
260: 1910-1916
[Abstract]
(1987). PRIMARY VENTRICULAR FIBRILLATION IN ACUTE MYOCARDIAL INFARCTION -- IS IT OMINOUS?. JWatch General
1987: 10-10
[Full Text]
